Evaluating the potency of tramadol as an adjuvant to intrathecal chloroprocaine.

Evaluating the efficacy of Tramadol as an adjuvant to intrathecal isobaric Chloroprocaine for the elective Infra-umbilical surgeriesâ?? - NA

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/04/018539

Enrollment

Registered

2019-04-10

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N210- Calculus in bladder

Interventions

Intervention1: chloroprocaine with tramadol intrathecally: Chloroprocaine 40mg Intrathecally 120 minutes Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: ASA grade I and II and posted for infra umbilical surgery under spinal anaesthesia

Exclusion criteria

Exclusion criteria: Pregnant, emergency, coagulation abnormalities, short stature, allergic to tramadol and local anaesthetic.

Design outcomes

Primary

Measure	Time frame
Duration of Anaesthesia and analgesiaTimepoint: Duration of Anaesthesia and analgesia	—

Secondary

Measure	Time frame
Duration of sensory and motor blockTimepoint: upto 3 hours	—

Countries

India

Contacts

Public ContactDr Dinesh Chand Meena

RNT Medical College, Udaipur

khemraj10@gmail.com9414759782

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026